Eloctate Audience Self-Identification Aug 31, 2016Aug 31, 2016 Brand: Eloctate (antihemophilic factor), Intravenous Infusion Parent Company: Biogen Drug Type: Prescription Drug Category: Hematology Campaign: Post-Launch Targeting: Patients, Caregivers Patient Website: http://www.eloctate.com/ HCP Website: https://www.eloctatepro.com/ Self-identification homepage feature Caregiver Young patient Adult patient